4887.T

Aug 6, 2026, 10:42 UTC

Sawai Pharmaceutical, under Sawai Group Holdings, will discontinue 46 generic drug products as inventory runs out, including 39 due to a major product portfolio restructuring to improve production efficiency and ensure stable supply of generics.